Correlation Between Crinetics Pharmaceuticals and Savara
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Savara at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Savara into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Savara Inc, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Savara and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Savara. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Savara.
Diversification Opportunities for Crinetics Pharmaceuticals and Savara
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Crinetics and Savara is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Savara Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Savara Inc and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Savara. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Savara Inc has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Savara go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Savara
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Savara. In addition to that, Crinetics Pharmaceuticals is 1.37 times more volatile than Savara Inc. It trades about -0.15 of its total potential returns per unit of risk. Savara Inc is currently generating about -0.18 per unit of volatility. If you would invest 272.00 in Savara Inc on November 29, 2024 and sell it today you would lose (25.00) from holding Savara Inc or give up 9.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 95.45% |
Values | Daily Returns |
Crinetics Pharmaceuticals vs. Savara Inc
Performance |
Timeline |
Crinetics Pharmaceuticals |
Savara Inc |
Crinetics Pharmaceuticals and Savara Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Crinetics Pharmaceuticals and Savara
The main advantage of trading using opposite Crinetics Pharmaceuticals and Savara positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Savara can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Savara will offset losses from the drop in Savara's long position.Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Savara vs. Stoke Therapeutics | Savara vs. Edgewise Therapeutics | Savara vs. Crinetics Pharmaceuticals | Savara vs. Dyne Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |